The experimental procedure that can reverse blindness

Vanna Belton had no reason to suspect she might lose her vision. She certainly wasn’t expecting it to happen at the age of 23, or for the blindness to come not over a span of years or even decades, but in just a few weeks.

It took a week in the hospital for Vanna to learn that she was suffering from an unexplained case of inflammation in her optic nerves. The inflammation blinded her for half a decade, until she met Dr. Jeffrey N. Weiss, an ophthalmologist in Florida providing experimental stem cell treatments to patients he says “have been told their whole lives, ‘You have no hope. You’re stuck.’”

Like the doctors Vanna had already seen, Weiss couldn’t tell her what caused the inflammation. But he suspected that taking stem cells from her hip bone and transplanting them to her retinas’ optic nerves might help repair the damage.

Three months after the procedure, Vanna was able to see her fiance’s face for the first time. Two years later, she has her life back.

“Close your eyes for 24 hours, and imagine that you never get to open them again. You’re willing to do more things than you realize,” Vanna says.  

Related
See how Moderna is using OpenAI tech across its workforce
A partnership between Moderna and OpenAI provides a real-world example of what can happen when a company leans into generative AI.
OpenAI’s GPT-4 outperforms doctors in another new study
OpenAI’s most powerful AI model, GPT-4, outperformed junior doctors in deciding how to treat patients with eye problems.
AI can help predict whether a patient will respond to specific tuberculosis treatments
Instead of a one-size-fits-all treatment approach, AI could help personalize treatments for each patient to provide the best outcomes.
In a future with brain-computer interfaces like Elon Musk’s Neuralink, we may need to rethink freedom of thought
In a future with more “mind reading,” thanks to computer-brain interfaces, we may need to rethink freedom of thought.
Personalized cancer vaccines are having a moment
Personalized cancer vaccines were a recurring theme at the annual meeting of the American Association for Cancer Research in 2024.
Up Next
Subscribe to Freethink for more great stories